#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Adenocarcinoma pancreas Extranodal marginal zone B-cell lymphoma (MALT type) Mantle cell lymphoma stage IV Erythema Oropharyngeal squamous cell carcinoma Neuroendocrine carcinoma metastatic Arrhythmogenic right ventricular dysplasia Conjunctivitis allergic Autoimmune demyelinating disease Squamous cell carcinoma of the oral cavity Dermatitis Becker's muscular dystrophy Graft versus host disease Cerebellar ataxia Hypereosinophilic syndrome More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Treatment Alternating hemiplegia of childhood – Trials in Disease Pulmonary sarcoidosis – Basic Information Synovial sarcoma Acute respiratory distress syndrome – Basic Information Usher’s syndrome – Trials in Disease Lymphangioma – Basic Information Congenital hypotransferrinaemia Congenital generalised lipodystrophy – Diagnostics Hereditary hypophosphataemic rickets – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ladarixin Amivantamab Levodropropizine Thiotepa Pyrimethamine SPY002 Medroxyprogesterone Acetate Ubiquinol Balcinrenone Faricimab Gad20-209-Fsp-A4 Prilocaine Anakinra Abc-23B-116 Etavopivat Trimethoprim Acasunlimab Sodium Nitrite Melphalan Hydrochloride Ripretinib More therapies…

    Learn about Your Condition

    External cephalic version Anorexia nervosa Type IIa hyperlipidaemia Alexander disease Arterial disorder Small fibre neuropathy Immunosuppression Cerebellar ataxia Dysmenorrhoea Thrombosis prophylaxis Hereditary angioedema Vulvovaginal candidiasis Mucopolysaccharidosis III Nephropathy Cervical dysplasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on 7-Day vs. 14-Day Antibiotic Treatment for Kidney Infection in Transplant Patients Using Bromhexine Hydrochloride, Trimethoprim, and Fluoroquinolones

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyelonephritis
    • Pyelonephritis acute
    • Renal transplant
    Investigated Drugs:
    • Bromhexine Hydrochloride
    • Sulfamethoxazole
    • Tolu Balsam
    France

  • Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome

    Recruiting

    3 1
    Investigated Diseases:
    • Lennox-Gastaut syndrome
    Investigated Drugs:
    • Carisbamate
    Germany Greece Hungary Italy Poland Portugal +1

  • Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Gastric cancer recurrent
    • Gastrooesophageal cancer
    • Gastric cancer
    Investigated Drugs:
    • Levoleucovorin
    • Tipiracil Hydrochloride
    • Tipiracil
    France

  • Study on Stopping Rituximab vs. Continuing Rituximab for Patients with ANCA-Associated Vasculitis in Stable Remission

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rituximab
    Austria Denmark Germany Iceland Ireland The Netherlands +1

  • Study on the Effects of Botulinum Toxin in Patients with Jaw Muscle Pain (TMD)

    Recruiting

    2 1 1 1
    Sweden

  • Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Rilvegostomig
    • Datopotamab Deruxtecan
    • Infliximab
    Austria Belgium Germany Hungary Italy Poland +1
Previous Page
1 … 507 508 509 510 511 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!